Microbot Medical 

$2.41
140
-$0-0% Today

Statistics

Day High
2.47
Day Low
2.37
52W High
4.67
52W Low
1.35
Volume
616,106
Avg. Volume
1,988,857
Mkt Cap
161.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.2
-0.15
-0.1
-0.05
Expected EPS
-0.083333
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-22.89MNet Income

Analyst Ratings

$7.50Average Price Target
The highest estimate is 12.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBOT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Microbot Medical's robotic technologies aimed at improving clinical outcomes.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers robotic-assisted surgery solutions, competing in the same space as Microbot Medical with its innovative medical devices for minimally invasive procedures.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew provides advanced surgical robotics for orthopedic procedures, competing with Microbot Medical in the broader field of robotic-assisted surgeries.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the development of robotic solutions for orthopedic surgeries, a market that overlaps with Microbot Medical's target for their robotic devices.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including robotic surgery systems, making it a competitor in the robotic-assisted surgical market alongside Microbot Medical.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Ethicon, is involved in the development of surgical robotics, competing with Microbot Medical's innovations in the same domain.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers products that compete in the minimally invasive medical device market, including endoscopy and interventional cardiology, areas where Microbot Medical also aims to innovate.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, while primarily known for its pharmaceuticals, has ventured into medical devices and robotics through acquisitions, indirectly competing with Microbot Medical's focus on robotic surgical solutions.
Alphabet
GOOGL
Mkt Cap3.4T
Alphabet Inc., through its Verily life sciences division, is exploring robotic surgery and other medical technologies, making it a potential future competitor in the innovative medical robotics space where Microbot Medical operates.

About

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Show more...
CEO
Mr. Harel Gadot
Employees
20
Country
US
ISIN
US59503A2042

Listings

0 Comments

Share your thoughts

FAQ

What is Microbot Medical stock price today?
The current price of MBOT is $2.41 USD — it has decreased by -0% in the past 24 hours. Watch Microbot Medical stock price performance more closely on the chart.
What is Microbot Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Microbot Medical stocks are traded under the ticker MBOT.
Is Microbot Medical stock price growing?
MBOT stock has fallen by -5.93% compared to the previous week, the month change is a -1.24% fall, over the last year Microbot Medical has showed a +59.73% increase.
What is Microbot Medical market cap?
Today Microbot Medical has the market capitalization of 161.84M
When is the next Microbot Medical earnings date?
Microbot Medical is going to release the next earnings report on May 12, 2026.
What were Microbot Medical earnings last quarter?
MBOT earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.06 USD resulting in a +16.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Microbot Medical revenue for the last year?
Microbot Medical revenue for the last year amounts to 0 USD.
What is Microbot Medical net income for the last year?
MBOT net income for the last year is -22.89M USD.
How many employees does Microbot Medical have?
As of April 01, 2026, the company has 20 employees.
In which sector is Microbot Medical located?
Microbot Medical operates in the Health Care sector.
When did Microbot Medical complete a stock split?
The last stock split for Microbot Medical was on September 05, 2018 with a ratio of 1:15.
Where is Microbot Medical headquartered?
Microbot Medical is headquartered in Hingham, US.